Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Proto Labs (NYSE:PRLB - Get Rating) announced its earnings results on Friday. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.07, Briefing.com reports. The business had revenue of $126.90 million for the quarter, compared to analysts' expectations of $127.28 million. Proto Labs had a return on equity of 2.95% and a net margin of 4.88%. The business's revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.47 EPS. Proto Labs Stock Down 0.7 %

Shares of Proto Labs stock traded down $0.32 during trading on Monday, reaching $46.58. The company's stock had a trading volume of 247,940 shares, compared to its average volume of 218,561. The company has a market cap of $1.28 billion, a price-to-earnings ratio of 52.93 and a beta of 1.28. Proto Labs has a 1-year low of $39.36 and a 1-year high of $82.98. The company has a 50-day simple moving average of $47.77 and a two-hundred day simple moving average of $49.09. Wall Street Analysts Forecast Growth

Separately, Craig Hallum dropped their target price on Proto Labs from $56.00 to $50.00 in a research report on Monday, May 9th.Institutional Trading of Proto Labs

A number of institutional investors have recently made changes to their positions in PRLB. Graham Capital Management L.P. boosted its position in shares of Proto Labs by 8.6% in the 1st quarter. Graham Capital Management L.P. now owns 6,351 shares of the industrial products company's stock worth $335,000 after purchasing an additional 501 shares in the last quarter. Hsbc Holdings PLC lifted its position in Proto Labs by 70.0% during the 1st quarter. Hsbc Holdings PLC now owns 8,441 shares of the industrial products company's stock worth $448,000 after acquiring an additional 3,475 shares during the period. GABELLI & Co INVESTMENT ADVISERS INC. lifted its position in Proto Labs by 36.8% during the 1st quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 13,000 shares of the industrial products company's stock worth $688,000 after acquiring an additional 3,500 shares during the period. MetLife Investment Management LLC lifted its position in Proto Labs by 35.4% during the 1st quarter. MetLife Investment Management LLC now owns 14,038 shares of the industrial products company's stock worth $743,000 after acquiring an additional 3,673 shares during the period. Finally, Gabelli Funds LLC lifted its position in Proto Labs by 17.2% during the 1st quarter. Gabelli Funds LLC now owns 16,759 shares of the industrial products company's stock worth $887,000 after acquiring an additional 2,459 shares during the period. Institutional investors and hedge funds own 93.35% of the company's stock. Proto Labs Company Profile (Get Rating)

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.See AlsoGet a free copy of the StockNews.com research report on Proto Labs (PRLB)How to Use the MarketBeat Dividend CalculatorTwo Appealing Biotech Stocks for Two Distinct investorsIs Tyson Foods A Buy On Post-Earnings Weakness? Is DoorDash Ready To Sprint Higher? Electric Vehicles Can Drive Alcoa Stock Higher

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

What investors can learn from studying the past, as well as offering some ideas about asset classes with future potential.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.